Literature DB >> 34547934

Cerebral Visual Impairment in CDKL5 Deficiency Disorder Correlates With Developmental Achievement.

Dylan Brock1,2, Andrea Fidell1,2, Jacob Thomas2, Elizabeth Juarez-Colunga2, Tim A Benke1,2, Scott Demarest1,2.   

Abstract

Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder is a rare neurodevelopmental disorder characterized by infantile-onset refractory epilepsy, profound developmental delays, and cerebral visual impairment. Although there is evidence that the presence of cerebral visual impairment in CDKL5 deficiency disorder is common, the potential impact of cerebral visual impairment severity on developmental attainment has not been explored directly. Focusing on a cohort of 46 children with CDKL5 deficiency disorder, examination features indicative of cerebral visual impairment were quantified and compared to developmental achievement. The derived cerebral visual impairment severity score was inversely correlated with developmental attainment, bolstering the supposition that cerebral visual impairment severity may provide a useful early biomarker of disease severity and prognosis. This study demonstrates the utility of a cerebral visual impairment score to better capture the range of cerebral visual impairment severity in the CDKL5 deficiency disorder population and further elucidates the interaction between cerebral visual impairment and developmental outcomes.

Entities:  

Keywords:  CDKL5 deficicency disorder; Cerebral vision impairment; developmental and epileptic encephalopathy; developmental outcome

Mesh:

Year:  2021        PMID: 34547934     DOI: 10.1177/08830738211019284

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

Authors:  Sam Amin; Marie Monaghan; Angel Aledo-Serrano; Nadia Bahi-Buisson; Richard F Chin; Angus J Clarke; J Helen Cross; Scott Demarest; Orrin Devinsky; Jenny Downs; Elia M Pestana Knight; Heather Olson; Carol-Anne Partridge; Graham Stuart; Marina Trivisano; Sameer Zuberi; Tim A Benke
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

2.  Negative impact of insomnia and daytime sleepiness on quality of life in individuals with the cyclin-dependent kinase-like 5 deficiency disorder.

Authors:  Jenny Downs; Peter Jacoby; Jacinta Saldaris; Helen Leonard; Tim Benke; Eric Marsh; Scott Demarest
Journal:  J Sleep Res       Date:  2022-04-12       Impact factor: 5.296

3.  Cortical Visual Impairment in CDKL5 Deficiency Disorder.

Authors:  Michela Quintiliani; Daniela Ricci; Maria Petrianni; Simona Leone; Lorenzo Orazi; Filippo Amore; Maria Luigia Gambardella; Ilaria Contaldo; Chiara Veredice; Marco Perulli; Elisa Musto; Eugenio Maria Mercuri; Domenica Immacolata Battaglia
Journal:  Front Neurol       Date:  2022-01-26       Impact factor: 4.003

4.  Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder.

Authors:  Joni N Saby; Patrick J Mulcahey; Alexis E Zavez; Sarika U Peters; Shannon M Standridge; Lindsay C Swanson; David N Lieberman; Heather E Olson; Alexandra P Key; Alan K Percy; Jeffrey L Neul; Charles A Nelson; Timothy P L Roberts; Timothy A Benke; Eric D Marsh
Journal:  Brain Commun       Date:  2022-08-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.